US Stock MarketDetailed Quotes
ARDS Aridis Pharmaceuticals
Watchlist
0.087
+0.006+7.41% Close 12/01 16:00 ET
0.088High0.075Low98.92KVolume
0.082Open0.081Pre Close8.25KTurnover0.26%Turnover RatioLossP/E (TTM)3.88MMarket Cap1.74652wk HighLossP/E (Static)44.57MShares0.05052wk Low-0.33P/B3.30MFloat Cap13.850Historical High--Dividend TTM37.96MShs Float0.050Historical Low--Div YieldTTM15.93%Amplitude0.083Avg Price1Lot Size
About Aridis Pharmaceuticals Company
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
Company Profile
SymbolARDS
Company NameAridis Pharmaceuticals
Listing Date08/14/2018
Issue Price13.00
Founded2014
CEODr. Vu Truong, PhD
MarketPink Market
Employees37
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address983 University Avenue,Building B
CityLos Gatos
ProvinceCalifornia
CountryUnited States of America
Zip Code95032
Phone1-408-385-1742
Websitehttp://www.aridispharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Vu Truong, PhD
- Director, Chief Executive Officer and Chief Scientific Officer
- 842.47K
- Fred Kurland
- Chief Financial Officer and Principal Accounting Officer
- 226.14K
- Dr. Hasan Jafri
- Chief Medical Officer
- 668.69K
- Dr. Eric Patzer, PhD
- Executive Chairman of the Board
- 794.57K
- John F. Hamilton
- Independent Director
- 57.50K
- Dr. Susan Richards Windham-Bannister, PhD
- Independent Director
- 51.97K